The molecular mechanism by which progesterone (P4) modulates the transport of ova and embryos along the oviduct is not fully resolved. We report a rapid response to P4 and agonists of g-aminobutyric acid receptors A and B (GABA A/B ) in the mouse oviduct that was characterized by oscillatory Ca 2+ signals and increased ciliary beat frequency (CBF). Pharmacological manipulation, genetic ablation, and siRNA-mediated knockdown in oviductal cells, as well as overexpression experiments in HEK 293T cells, confirmed the participation of the cationic channel TRPV4, different subunits of GABA A (a1 to a3, b2, and b3), and GABA B1 in P4-induced responses. TRPV4-mediated Ca 2+ entry in close proximity to the inositol trisphosphate receptor was required to initiate and maintain Ca 
INTRODUCTION
Progesterone (P4) is present at high concentrations (up to 9 mM) in the ovarian secretions into the fimbriae and peritoneum in humans (1) , as well as in the hamster oviduct, where it reaches a concentration of 500 nM (2) . In the oviduct, P4 affects muscle and epithelial cells, as well as sperm (3) . Early reports showed that the administration of progestogens accelerates the transport of eggs from the oviduct to the uterus in several animal species (4) (5) (6) . In the ciliated epithelium of the oviduct, the transport of gametes and embryos relies on the maintenance of the appropriate velocity of mucociliary transport (7) , which, in turn, is driven by ciliary beat frequency (CBF) (8) . However, a number of studies showed that oviductal (9) (10) (11) and tracheal (12) CBF is reduced by long-term administration of P4 (the first effects occur 20 to 30 min after hormone addition and are maintained for 24 to 36 hours in the presence of hormone), as well as during the periods of the ovarian cycle with increased P4 amounts (13) , which contradicts the reported P4-mediated acceleration of egg transport in the oviduct. There is also controversy about the involvement of the classical P4 receptor in CBF reduction, with studies both supporting (11) and questioning (9) its participation.
Steroid hormones exert their long-term actions through receptors that function as transcription factors (14) . Rapid, nongenomic actions of steroid hormones have also been reported (15) (16) (17) . In addition to the first description of the rapid anesthetic effect of P4 due to the modulation of the ligand-gated g-aminobutyric acid receptor A (GABA A ) chloride channel (18) (19) (20) , other nongenomic mechanisms of action of P4 have been described (21) . Rapid generation of Ca 2+ signals has been found in diverse tissues (22) (23) (24) (25) . Although both Ca 2+ release from the endoplasmic reticulum (ER) and Ca 2+ entry through plasma membrane channels have been reported in response to P4, the molecular players participating in such responses remain largely unknown, except for examples such as the steroid-activated CatSper (26, 27) and TRPM3 (28) cationic channels. Considering that intracellular Ca 2+ is a key regulator of the CBF (8, 29) , we sought to identify whether P4 regulated CBF through the modulation of Ca 2+ signaling in oviductal ciliated cells. We found that P4 increased the intracellular concentration of Ca 2+ through a mechanism that required both the TRPV4 channel, which produces Ca 2+ signals linked to CBF modulation (30) (31) (32) (33) , and GABA receptors, which are the main inhibitory receptors in the mammalian central nervous system (34) . GABAergic signaling involving the ligand-gated GABA A chloride channel and the metabotropic G i/o protein-coupled GABA B receptor has been found in epithelial tissues (35) (36) (37) . The GABA A channel is a pentameric complex formed by the combination of two or three different subunits (38, 39) , whereas the metabotropic GABA B receptor is a heterodimer composed of the agonist-binding GABA B1 and the G i/o protein-coupled GABA B2 subunits (40) . Steroids bind to GABA A at the a subunit, b subunits, or both (the ab interface), although other subunits may also participate (19, 41, 42) . No interaction of steroids with the GABA B receptor has been documented to date (43) . Here, we report a close functional interaction between the cationic channel TRPV4 and GABA A/B receptors that promoted rapid responses to P4 in oviductal ciliated cells.
RESULTS
The production of rapid, P4-induced intracellular Ca 2+ signals in oviductal ciliated cells requires TRPV4 Monitoring the intracellular Ca 2+ concentration in Fura-2-loaded ciliated oviductal cells from mice showed that treatment with vehicle alone (Fig. 1A) did not affect the intracellular Ca 2+ concentration, whereas rapid oscillatory Ca 2+ signals were generated in response to 100 nM P4 in about 25% of the ciliated cells (Fig. 1B) . We also examined the responses of ciliated oviductal cells to 10 nM and 10 mM P4 ( fig. S1,  A 1C) , suggesting a need for the generation of inositol 1,4,5-trisphosphate (IP 3 ) and the release of Ca 2+ from the ER in the P4-mediated response. This hypothesis was further confirmed by depleting the ER Ca 2+ stores with thapsigargin, a sarco-ER Ca 2+ pump inhibitor (Fig. 1D) , and using the IP 3 receptor (IP 3 R) inhibitor xestospongin C (Fig. 1E ). Both actions prevented the generation of P4-induced Ca 2+ signals. In addition to playing a role in mechanosensitive and osmosensitive signaling in ciliated cells (44) , the TRPV4 cationic channel interacts with and shows reciprocal modulation by the IP 3 R (31, 32), suggesting that it may participate in the generation of P4-mediated Ca 2+ signals. Therefore, we tested whether pharmacological or genetic ablation of TRPV4 affected this response. P4 did not elicit Ca 2+ signals in Trpv4 −/− cells or in Trpv4 +/+ cells treated with the TRPV4 antagonist HC067047 (Fig. 1, F and G) . Direct activation of TRPV4 by P4 was absent in isolated ciliated oviductal cells and in TRPV4-overexpressing human embryonic kidney (HEK) 293T cells ( fig. S2, A and B) , suggesting that basal TRPV4 activity is sufficient to promote P4-induced Ca 2+ signals. Although classical and plasma membrane P4 receptors are present in the ciliated epithelia of the oviduct (45, 46) , we found that their treatment with the P4 receptor antagonist RU-486 and 1(S),2(R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanolan (D-eMAPP) (47), respectively, failed to inhibit the P4-induced Ca 2+ response (Fig. 1G) . Finally, pretreatment with pertussis toxin (PTX), which inhibits the activation of G i/o proteins, prevented P4-induced Ca 2+ signals (Fig.  1G) . Together, these experiments suggested a rapid, nongenomic effect of P4 that was independent of the activity of classical and plasma membrane P4 receptors but required the involvement of G i/o proteins, the generation of IP 3 , the release of Ca 2+ from the ER, and the participation of the TRPV4 channel.
Progesterone uses GABA receptor signaling to stimulate Ca 2+ responses in oviductal ciliated cells In searching for the signaling pathway activated by P4, we focused on the GABAergic system, because it is capable of binding to progestogens (19) , is linked to G i/o proteins (40) , is found in the oviduct (35, 36) , and can modulate ciliary activity in Paramecium (48) . Considering that steroid binding to GABA A uses different combinations of subunits (49), we first examined which GABA A -encoding mRNAs were found in the mouse oviduct by reverse transcription polymerase chain reaction (RT-PCR) analysis. We found that the genes encoding GABA A a1 to a4, b1 to b3, g3, and d subunits, as well as GABA B1 were expressed in the oviduct ( fig. S3 ). Note that the gene encoding GABA B2 was not expressed. GABA B2 is proposed to promote the cell surface expression of GABA B1 and to couple to G i/o proteins (40) , although there is evidence of atypical GABA B1 trafficking to the plasma membrane and activation of G i/o pathways in the absence of GABA B2 (50) (51) (52) .
To check the functionality of GABA receptors, we used specific agonists of GABA B (baclofen) and GABA A (muscimol) and measured intracellular Ca 2+ concentrations in primary cultures of mouse oviductal ciliated cells. Similar to P4, baclofen elicited oscillatory Ca 2+ signals in cultures obtained from Trpv4 +/+ mice ( Fig. 2A) . These responses were absent in cultures obtained from Trpv4 −/− mice and challenged with baclofen ( Fig. 2B ) and in Trpv4 +/+ cells treated with P4 in the presence of CGP35348, a specific antagonist of GABA B (Fig.  2C) . Muscimol also generated oscillatory Ca 2+ signals in Trpv4 +/+ cells ( Fig. 2D) but not in Trpv4 −/− cells (Fig. 2E) . The GABA A antagonist bicuculline prevented P4-induced responses in Trpv4 +/+ cells (Fig. 2F) . Both of the GABA receptor antagonists were equally effective on cells previously activated by P4 ( fig. S4 ). The responses to baclofen and muscimol were absent in cultures obtained from Trpv4 +/+ mice and treated with the TRPV4 antagonist HC067047 (Fig. 2, G and H) . These experiments demonstrated that GABA receptor agonists and P4 shared a common mechanism for generating Ca 2+ signals that required TRPV4. Given that inhibitors of both GABA A and GABA B prevented P4 responses but steroids have only been shown to bind to GABA A receptors (43), we hypothesized that the sequence of events leading to P4-mediated Ca 2+ oscillations was initiated by the interaction of P4 with GABA A followed by the transactivation of GABA B .
To test whether activation of GABA A was upstream of GABA B , we performed experiments combining specific agonists and antagonists of these receptors. The Ca 2+ response to the GABA A agonist muscimol was prevented in the presence of the GABA B antagonist CGP35348 (Fig. 2I) , whereas the response to the GABA B agonist baclofen was insensitive to the GABA A antagonist bicuculline (Fig. 2J) , which suggests that the activation of GABA A was upstream of GABA B activation. This sequence of events fits with the hypothesis that P4 binds to GABA A (20) and uses GABA A to activate GABA B and stimulate the subsequent release of Ca 2+ from the ER through a G i/o -PLC-IP 3 pathway. We were unable to measure GABA A chloride currents in ciliated oviductal cells in response to GABA ( fig. S2D ), suggesting that the GABA A subunits present in these cells may form a complex that is capable of binding to steroids and stimulating Ca 2+ signals but that they are unable to generate a functional GABA A chloride channel.
GABA A and GABA B1 physically interact with each other and become activated To further investigate the molecular mechanism used by P4 to stimulate TRPV4-dependent Ca 2+ responses, we combined native tissue and heterologous expression systems to directly test two underlying premises of our model: first, the interaction between the GABA A and GABA B1 subunits, which was previously reported in heterologous expression systems (50) , and second, the activation of G i/o proteins in response to P4 receptor and GABA receptor agonists. The presence of GABA A and GABA B1 subunits in ciliated cells was examined by confocal immunofluorescence microscopy of mouse oviduct slices using antibodies against GABA Aa2 , GABA B1 , acetylated a-tubulin (to detect cilia), and TRPV4. We found that GABA A/B receptors were localized to ciliated epithelial cells that also had TRPV4 ( S5C ). Next, we evaluated the physical interaction between GABA A and GABA B1 receptor subunits in native oviductal tissue and heterologous expression systems. First, we tested for the presence of GABA Aa2 , GABA B1 , and TRPV4 in oviduct lysates ( fig. S5D ). Immunoprecipitates obtained from mouse oviduct lysates with antibodies against GABA B1 , TRPV4, or GABA Aa2 were analyzed by Western blotting for the presence of GABA B1 (Fig. 3B) . We found that GABA B1 coimmunoprecipitated with GABA Aa2 but not with TRPV4. Similar results were obtained when we analyzed the proximity of GABA Aa1 -YFP (yellow fluorescent protein) and GABA B1 -CFP (cyan fluorescent protein) using the fluorescence resonance energy transfer (FRET) technique, as previously described (53, 54) . The FRET signal was statistically significantly increased with the coexpression of GABA Aa1 -YFP and GABA B1a -CFP in HEK 293T cells, but not when GABA Aa1 -YFP or GABA B1a -CFP was coexpressed with unfused CFP or YFP, respectively ( Fig. 3C and fig. S6 ). A study previously showed a direct interaction between GABA B1 and the TRPV1 channel (55) , one that modifies channel desensitization through a noncanonical GABAergic mechanism: It does not require the presence of the GABA B2 subunit, involves a direct interaction between TRPV1 and GABA B1 , and is independent of signaling downstream of GABA B . Our coimmunoprecipitation experiments performed with mouse oviductal tissue did not provide evidence of a similar physical interaction between TRPV4 and GABA B subunits. To further confirm this observation, we expressed YFP-or CFP-tagged GABA B1 , GABA B2 , and TRPV4 proteins in HEK 293T cells and analyzed any potential interactions by FRET. We observed a statistically significant increase in FRET signal when TRPV4-YFP was coexpressed with TRPV4-CFP and when GABA B1 -CFP was coexpressed with GABA B2 -YFP (Fig. 3D) , indicating the formation of the respective TRPV4 (53) and GABA B (56) multimeric complexes, but not when TRPV4-CFP or GABA B1 -YFP was coexpressed either with or without GABA B2 (Fig. 3D) . We then used bioluminescence resonance energy transfer (BRET) to study the conformational rearrangements of G protein subunits during their activation. A study previously showed that after the binding of agonists to the GABA B receptor, the BRET ratio decreases during , GABA Aa1 -YFP and CFP (n = 5), or GABA B1 -CFP and GABA Aa2 -YFP (n = 6). Data are means ± SEM. *P < 0.05 when comparing all pairwise conditions (as determined by Kruskal-Wallis one-way ANOVA followed by Dunn's method for multiple comparisons). (D) Study of the proximity between GABA B and TRPV4 proteins expressed in HEK 293T cells. FRET efficiencies are expressed as the increase in the FRET donor CFP after bleaching the FRET acceptor YFP. FRET efficiency was determined at the plasma membrane of HEK 293T coexpressing soluble CFP and TRPV4-YFP, CFP-and YFP-fused TRPV4, GABA B1 -CFP and GABA B2 -YFP, TRPV4-CFP and GABA B1 -YFP, and GABA B2 or TRPV4-CFP and GABA B1 -YFP. ***P < 0.001 when comparing soluble CFP and TRPV4-YFP to any other condition, as determined by oneway ANOVA followed by Bonferroni post hoc test. (E) Baclofen-and P4-induced changes in the BRET ratio were determined in HEK 293T cells expressing GABA B1-2 receptors, G ai/o -RLuc, G g2 -Venus, and G b2 or in HEK 293T cells expressing the a 2 -AR, G ai/o -RLuc, G g2 -Venus, and G b2 . The numbers of experiments (each performed in triplicate) are shown for each condition. *P < 0.05 and **P < 0.01 compared to vehicle, as determined by one-way ANOVA followed by a Bonferroni post hoc test. NS, not significant; NA, not applicable.
G protein activation because of the conformational rearrangements of the G ai/o -RLuc and G g2 -Venus subunits (57) . Consistent with the activation of G proteins by P4 receptor and GABA B agonists, both P4 and baclofen, but not the vehicle, induced changes in the BRET ratios in HEK 293T cells overexpressing GABA B1 and GABA B2 receptors, G ai/o -RLuc, G g2 -Venus, and G b2 (Fig. 3E) . No substantial effects of baclofen or P4 were observed in HEK 293T cells overexpressing the a 2 -adrenergic receptor (a 2 -AR), G ai/o -RLuc, G g2 -Venus, and G b2 . We used noradrenaline as a positive control to stimulate decreases in BRET after activation of the a 2 -AR (Fig. 3E) . (Fig. 4 and fig. S7 ). HEK 293T and HEK 293WSS1 cells, stably overexpressing a1, b2, and g2 GABA A subunits (58), were used. First, we detected by RT-PCR the expression of GABA subunits in both cell lines ( fig. S7, A to D) . HEK 293WSS1 cells expressed no GABA B subunits, whereas HEK 293T cells expressed GABA B2 and a truncated, inactive form (GABA B1e ) typically found in the peripheral nervous system and other tissues ( fig. S7D) (59) . In HEK 293T cells transfected to express GABA B receptors or TRPV4 alone, P4 (Fig. 4, A to C (Fig. 4D ) occurred when TRPV4 was coexpressed with GABA B1 and GABA B2 , a response that was prevented in the presence of the TRPV4 inhibitor HC067047 (Fig. 4E) . We calculated the mean percentages of HEK 293T cells overexpressing different combinations of GABA B receptor subunits and the TRPV4 channel that responded to P4 (Fig. 4G) . A statistically significant increase in the percentage of HEK 293T cells responding to P4 with changes in intracellular Ca 2+ concentration only occurred when TRPV4 was coexpressed with GABA B1 in the presence or absence of GABA B2 (Fig.  4G) . Pharmacological manipulations in HEK 293T cells overexpressing TRPV4 and GABA receptors (Fig. 4H) provided similar results to those obtained from mouse oviduct cultures: The response to P4 was prevented in cells treated with U73122 (PLC inhibitor), HC067047 (TRPV4 inhibitor), CGP35348 (GABA B inhibitor), or bicuculline (GABA A inhibitor) or when extracellular Ca 2+ was removed. Similar to HEK 293T cells, HEK 293WSS1 cells, stably overexpressing GABA A subunits, generated Ca 2+ signals in response to muscimol, P4, and baclofen when both GABA B and TRPV4 were transiently overexpressed ( fig. S7F ). Moreover, a statistically significantly increased percentage of cells responded to P4 when only the GABA B1 subunit was coexpressed with TRPV4 in HEK 293WSS1 cells, which do not express endogenous GABA B subunits ( fig. S7F ). Together, these results suggest that the endogenous amounts of GABA A present in HEK 293T cells are sufficient to maintain the response to P4. However, similar to the native tissue, HEK 293T cells were not capable of producing GABA Amediated chloride currents ( fig. S2C ), which were only recorded in HEK 293WSS1 cells ( fig. S2E ). To further confirm the participation of GABA A subunits in the response of transfected HEK 293T cells to P4, we knocked down various GABA A subunits in HEK 293T cells, both individually and in combination (Fig. 5) . HEK 293T cells transiently overexpressing GABA B1 , GABA B2 , and TRPV4 were transfected with a control small interfering RNA (siRNA) or with siRNAs individually targeting genes encoding GABA Aa1 to GABA Aa3 , GABA Ab2 , and GABA Ab3 , or a pool or siRNAs targeting genes encoding all five GABA A subunits. Quantitative PCR analysis showed that the mRNAs of genes encoding GABA A subunits were decreased in abundance by 50 to 70% when the cells were treated with the corresponding siRNAs (Fig. 5A) . Changes in intracellular Ca 2+ flux in HEK 293T cells were recorded in response to P4, and the area under the curve for each individual cell trace was integrated (Fig. 5B) . A consistent reduction in the P4-induced Ca 2+ signal was observed in HEK 293T cells transfected with pooled siRNAs targeting all five GABA A subunits, as well as with siRNA targeting GABA Aa2 alone (Fig. 5B) . There was also a trend toward a reduced Ca 2+ response in cells treated with siRNA targeting GABA Aa3 , but this did not reach statistical significance. Consistent with the view that multiple combinations of different GABA A subunits support the interaction with steroids, we observed that the largest decrease in the response of the cells to P4 was obtained using a pool of siRNAs targeting GABA A subunits to simultaneously reduce the abundances of all GABA A subunits that may mediate the interaction with P4.
P4-mediated
Ca 2+ signals can be reconstituted in HEK 293 cells We next tested whether P4-stimulated increases in intracellular Ca 2+ concentration could be reconstituted in cell systems commonly used for heterologous expression
The interaction of TRPV4 with IP 3 R is involved in the response of cells to P4
There is a close interaction between TRPV4 and IP 3 R, as described previously for ciliated epithelial cells (31) and heterologous expression centration in response to 100 nM P4 when overexpressing different combinations of TRPV4 and GABA receptors. Drugs were used at the following concentrations: 10 mM HC067047, 2 mM U73122, 100 mM CGP35348, and 10 mM bicuculline. The number of coverslips used for each condition is shown for each bar. Data are means ± SEM. *P < 0.05 and ***P < 0.001 when comparing P4-treated nontransfected cells with any other condition, as determined by one-way ANOVA followed by a Bonferroni post hoc test. , a response that is magnified by the sensitizing effect of Ca 2+ entry through plasma membrane channels situated in close proximity to the IP 3 R (31, 61). To test this hypothesis, we used a TRPV4 mutant (TRPV4DCaM) that lacks the IP 3 R-binding site located between amino acid residues 812 and 831 and therefore is unable to physically interact with the IP 3 R (31, 60). We found that there was no statistically significant Ca 2+ response to P4 when GABA B receptors were coexpressed with TRPV4DCaM (Fig. 4, F and G) .
P4 has short-and long-term effects on CBF Ca 2+ signals, which are mostly oscillatory and generated at the base of the cilia, are linked to increased CBF in different ciliated cells (8, 29, 62, 63) . To test this association in our experimental model, we measured intracellular Ca 2+ concentrations and CBF in Trpv4 +/+ and Trpv4 −/− oviductal cells using high-speed digital video microscopy (32) . Trpv4 +/+ cells presented greater basal CBF, which was consistent with the larger percentage of Trpv4 +/+ cells presenting spontaneous Ca 2+ oscillations (Fig. 6A) . We also demonstrated the TRPV4-dependent increase in CBF obtained after the addition of the TRPV4 agonist GSK1016790A (64) . CBF increased in response to GSK1016790A only in Trpv4 +/+ ciliated oviductal cells (fig. S8) +/+ mice, unlike those obtained from Trpv4 −/− mice, rapidly exhibited increased CBF after the addition of P4 (Fig. 6 , B and C). This response was potentiated using warmed solutions (Fig. 6B) , which were previously shown to increase the activity of TRPV4 (54, 65) , and prevented by incubation with the PLC inhibitor U73122 but was insensitive to the P4 receptor antagonist RU-486 (Fig. 6C) . Furthermore, and consistent with previous reports (11), CBF decreased in response to the classical progesterone receptor (PR) agonist R5020 (Fig. 6C) , which does not interact with GABA A receptors at this low concentration (66) . CBF did not change after the addition of 10 nM estradiol ( fig. S9) . Consistent with the action of GABA A and GABA B agonists on Ca 2+ signaling, muscimol and baclofen increased CBF, but only in Trpv4 +/+ oviductal cells (Fig. 6D) . In addition, the increase in CBF induced by baclofen was prevented in the presence of the GABA B antagonist CGP35348 (Fig. 6D) . The change in CBF in response to P4 and its sensitivity to RU-486 showed a different pattern when the CBF was measured 12 hours after the addition of the hormone (Fig. 6E ). Under these experimental conditions, P4 reduced CBF and this effect was reversed by the addition of RU-486, supporting previous reports demonstrating that P4 reduces CBF in a PR-dependent manner at times ≥20 min (11) .
DISCUSSION
Here, we sought to determine whether P4 regulated CBF through the modulation of Ca 2+ signaling in ciliated oviductal cells. The combination of experiments with native mouse oviductal ciliated cells and with heterologous expression of GABA A , GABA B , and TRPV4 reported the following observations: (i) the contribution of GABA A , GABA B1 , and TRPV4 to the P4-stimulated Ca 2+ responses; (ii) the physical interaction between the GABA A and GABA B1 subunits; and (iii) the GABA receptordependent activation of G proteins by P4. Heterologous expression in HEK 293 cells also enabled us to add a further element to this molecular mechanism: the need for TRPV4 to be in close proximity to the IP 3 R. Ca 2+ entry is required for continuous ER-dependent Ca 2+ oscillations, and TRPV4 plays a role in such process (31, 32) . Therefore, basal TRPV4-mediated Ca 2+ entry in close proximity to the IP 3 R seems to be required to initiate and maintain the Ca 2+ signals triggered by P4, a process that was lost when the TRPV4-IP 3 R interaction was prevented in cells expressing the mutant TRPV4DCaM, which lacks the IP 3 R-binding site. integrated for a period of 15 min after the addition of 100 nM P4 to HEK 293T cells, which were also transfected to express TRPV4, GABA B1 , and GABA B2 . The number of cells analyzed for each condition is shown for each bar. *P < 0.05 and **P < 0.01 when comparing control siRNA-transfected cells with any other condition, as determined by one-way ANOVA followed by a Bonferroni post hoc test. a.u., arbitrary units.
Our findings suggest two patterns of action of P4 regarding the control of CBF in mouse ciliated oviductal cells (Fig. 7) : a classical, P4 receptor-dependent, long-term effect, which is characterized by a decrease in CBF, and a short-term effect, which is characterized by the increase in intracellular Ca 2+ concentration and CBF that is mimicked by the addition of GABA receptor agonists. The data also highlight a previously unknown molecular mechanism for the rapid effect of P4 in mouse ciliated oviductal cells that involves the orchestrated action of GABA receptors and the TRPV4 channel to generate Ca 2+ signals and accelerate CBF. Note that female Gaba B1 −/− mice exhibit fertility problems that are characterized by a reduced percentage of pregnancies within the first 30 days of mating and a lengthened interval between the exposure of female mouse to a male mouse and the delivery of the first litter, although this difference did not attain statistical significance when compared with wild-type mice (67) . A detailed analysis of the different fertility parameters of Trpv4 −/− mice may be worth exploring in future studies. As previously reported (11), the long-term P4-mediated reduction in CBF required the participation of classical P4 receptors. The molecular mechanism of the P4-mediated reduction in CBF has not yet been delineated but may involve inhibition of Trpv4 expression by classical P4 receptors (68) . However, and at odds with the report by Bylander et al. (11) , rather than observing a reduction in CBF at short times (<20 min) after P4 administration, we observed an increase. The apparent contradiction between these two studies may be related to the age of the animals used: Immature mice were used in the other study, whereas we used adult mice in the present study. How age may affect the CBF response of mouse ciliated oviductal cells to P4 has not yet been studied but may be linked to changes in the abundances of GABA receptors that occur during maturation and aging (69, 70). The physical interaction and cross-activation of GABA B by GABA A adds to the list of described interactions between receptors belonging to different families, including GABA A , purinergic P2X, and dopamine D1 and D5 receptors (71, 72) . However, unlike these examples, the interaction we described between GABA A and GABA B receptors is destined because (i) it did not require a functional ionotropic GABA A receptor and (ii) it involved only GABA B1 , and not GABA B2 , subunits. The stoichiometry of the GABA A /GABA B complex and the question of whether other plasma membrane Ca 2+ -permeable channels can substitute for TRPV4 in this functional complex remain to be investigated.
MATERIALS AND METHODS

Reagents
All chemicals were purchased from Sigma-Aldrich except for fura-2 AM, which was obtained from Molecular Probes, Invitrogen. The isotonic bathing solutions used for imaging experiments contained 140 mM NaCl, 5 mM KCl, 1.2 mM CaCl 2 , 0.5 mM MgCl 2 , 5 mM glucose, and 10 mM Hepes (pH 7.4) and were 300 mosmol/liter. Ca 2+ -free extracellular solutions were obtained by replacing CaCl 2 with MgCl 2 and adding 0.5 mM EGTA. Primers used for RT-PCR analysis are listed in tables S1 and S2. Whole-brain extracts were used as positive controls. CBF measurements were performed in an isotonic extracellular solution. For electrophysiology bathing solutions, CaCl 2 was removed and 1 mM MgCl 2 and 1 mM EGTA were added.
Cells
Adult (10-to 14-week-old) Trpv4 +/+ and Trpv4 −/− littermate mice generated on a C57Bl6/J background were used (73) . Primary cultures were prepared as previously described (31) . Animals were maintained, and the experiments were performed according to the guidelines issued by the Institutional Ethics Committees of the Institut Municipal d'Investigació Mèdica/Universitat Pompeu Fabra. HEK 293T and HEK 293WSS1 cells were transfected with different combinations of the following complementary DNAs (cDNAs): HA-GABA B1a -YFP-pRK6 or myc-GABA B1a -pCI; HA-GABA B2 -YFP-pCI or HA-GABA B2 -pCI, TRPV4-pCDNA3.
Measurement of intracellular Ca
2+ concentration Cytosolic Ca 2+ signals were determined at room temperature (~24°C, unless otherwise indicated) in ciliated cells loaded with 4.5 mM fura-2 AM for 45 min, as previously described in detail (31) . Changes in the intracellular Ca 2+ concentration are presented as the ratio of emitted fluorescence at 510 nm after dual excitation at 340 and 380 nm relative to the ratio measured before stimulation (ratio, 340:380)
Measurement of CBF
The CBF of cultured ciliated cells was detected and quantified with high-speed digital imaging, as previously described (32) . Phase-contrast images (512 × 512 pixels) were collected at 130 frames s −1 with a highspeed charge-coupled device camera using a frame grabber and recording software from Video Savant (IO Industries). The CBF was determined from the variation in the light intensity of the image that resulted from the repetitive motion of cilia. Video recordings of beating cilia for a duration of 2 s were analyzed using Video Savant software, and the frequency of each ciliary beat cycle was determined from the period of each gray-intensity waveform cycle.
Immunodetection
Mouse oviducts were fixed overnight at 4°C with 4% paraformaldehyde, cryopreserved with 30% sucrose for 24 hours at 4°C, and embedded into optimal cutting temperature (OCT) for sectioning with a cryostat (10-mm sections). The rabbit polyclonal anti-TRPV4 antibody was used at a final concentration of 6.4 mg/ml together with GABA-specific antibodies (rabbit polyclonal anti-GABA Aa2 from Alomone Labs and rabbit polyclonal R-300 GABA B1 from Santa Cruz Biotechnology) at a 1:100 dilution. The immunogenic peptide for the GABA Aa2 antibody was provided by Alomone Labs and used at an antibody-peptide ratio of 1:1. For immunodetection, we used an Alexa Fluor 488-conjugated goat anti-rabbit immunoglobulin G (IgG) (Molecular Probes) and an Alexa Fluor 555-conjugated goat anti-mouse IgG (Molecular Probes) diluted at 1:750 in the same solution used with the primary antibodies. Images were captured with an inverted Leica SP2 confocal microscope, using an HCX PL APO 40× 1.25 Oil Ph3 CS objective, LCS Leica Confocal software, and an argon (488 nm, JDS Uniphase Corporation) laser. Original images were not further processed except for adjustments of brightness, contrast, and color balance. For Western blotting analysis, proteins were resolved on a precast 4 to 12% polyacrylamide gel NuPAGE (Invitrogen) and transferred to nitrocellulose membranes using a dry blotting system (iBlot, Invitrogen) according to standard protocols. Detection of immunoreactive bands was performed with SuperSignal West chemiluminescent substrate (Pierce).
Immunoprecipitation assay
Mouse oviducts were removed, homogenized, and resuspended in radioimmunoprecipitation assay buffer (25 mM tris-HCl, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) containing 10% protease inhibitor cocktail (Roche). Insoluble material was removed by centrifugation at 12,000g for 20 min at 4°C. Soluble proteins (about 500 mg per condition) were incubated overnight with protein G magnetic Dynabeads (Thermo Fisher) coated with antibodies against GABA Aa2 (rabbit polyclonal from Alomone Labs), GABA B1 (rabbit polyclonal R-300 from Santa Cruz Biotechnology), and TRPV4 (rabbit polyclonal) and incubated overnight at 4°C. Immunoprecipitates were then washed four times with lysis buffer, resuspended in Laemmli sample buffer with 5% b-mercaptoethanol, and boiled for 7 min. The samples were subjected to SDS-polyacrylamide gel electrophoresis using an 8% gel and transferred to nitrocellulose membranes using a dry blotting system (iBlot, Invitrogen). Membranes were blocked for 1 hour in tris-buffered saline, 0.1% Tween 20 containing 5% skim milk. Membranes were then incubated with antibody against GABA B1 at a 1:400 dilution. A donkey anti-rabbit secondary antibody (GE Healthcare) was used at a 1:2000 dilution.
FRET and BRET experiments FRET and BRET experiments were performed as previously described (53, 74) . FRET between CFP and YFP in cells expressing the corresponding constructs was determined by donor recovery after acceptor bleaching; if FRET occurs, photobleaching of the acceptor (YFP) yields a substantial increase in the fluorescence of the donor (CFP). BRET measurements were performed in HEK 293T cells transiently transfected with plasmids encoding GABA B1 and GABA B2 , pcDNA3-G ai/o1 -RLuc8, pcDNA3.1-G g2 -Venus, and pcDNA3.1-FLAG-G b2 or with plasmid encoding the a 2 -AR, G ai/o -RLuc, G g2 -Venus, and G b2 . BRET signals between G ai/o -RLuc and G g2 -Venus in the presence of 5 mM coelenterazine h (NanoLight Technology) were measured on a POLARstar OPTIMA plate reader (BMG Labtech) after receptor activation with baclofen, P4, or noradrenaline, as appropriate.
RT-PCR analysis
Total RNA from HEK 293T cells was isolated with the NucleoSpin RNA Isolation Kit (Macherey-Nagel). cDNAs were synthesized with the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen). Real-time PCR was performed using primers specific for the human GABA receptors. Actb was used as an internal control for the quantification of gene expression. Real-time PCR was performed with the SYBR Green PCR Master Mix (Applied Biosystems) in a 7900 HT Sequence Detection System (Applied Biosystems). Relative mRNA abundance in triplicate samples was calculated using the DDC T method.
Statistical analysis
All data are presented as means ± SEM. Statistical analysis was performed using GraphPad InStat or SigmaPlot software, applying either Student's paired or unpaired t tests and one-way ANOVA followed by the Bonferroni post hoc test, as appropriate, when comparing data that followed normal distributions or Mann-Whitney's unpaired t test and nonparametric ANOVA (Kruskal-Wallis) followed by Dunn's post hoc test when data did not fit a normal distribution. The criterion for a statistically significant difference was P < 0.05. Table S1 . Primers used to detect mouse GABA receptor subunits by RT-PCR. Table S2 . Primers used to detect human GABA receptor subunits by RT-PCR.
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